The plan was to sell the MPS asset, set a high price on the drug so that when it was released for KOA noone would scoff at a minimum price of $2.5k USD. Figures of $50-$100mn USD upfront were thrown around by Scott for MPS.
These expectations were well and truly lowered in the AGM when the company said that $10mn was more realistic. After the MPS VI result we will be lucky to get any ideal.
So the plan then pivoted to a Chinese deal which was mooted just prior to having a cr dumped on us. This was meant to last until mid 2025 but will be lucky to get us through to the second half of this year.
Who knows what the plan is now the FDA are going to take their time.........sell our potential future royalties? The share price is just a reflection of our lack of leadership, let the market wonder how this company survives rather than front foot it.
Where we at?, page-125
-
- There are more pages in this discussion • 582 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 99346 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 131244 | 5 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |